Phoenix Nest Inc

Phoenix Nest Inc is a biotech company based in Brooklyn, NY, dedicated to finding treatments for Sanfilippo syndrome. They actively seek strategic pharmaceutical partnerships and collaborations with academic and industry groups to advance their mission and bring innovative therapies to the clinic. With a focus on funding technologies that have the potential to address Sanfilippo syndrome, Phoenix Nest Inc offers an ideal partnership opportunity for those seeking to reach the proof-of-concept stage and beyond. Additionally, they are open to discussions with likeminded companies interested in supporting their journey through the challenges of drug development.Generated from the website

Cresilon, Inc is a Brooklyn-based company specializing in innovative technology solutions for the medical field. Their flagship product, VETIGEL, is a groundbreaking gel that has revolutionized wound care in veterinary medicine. With a team of experienced professionals and a commitment to excellence, Cresilon, Inc is dedicated to improving the lives of animals through cutting-edge advancements in medical technology. Driven by a passion for innovation, Cresilon, Inc has developed a range of products including TRAUMAGEL and Cresilon, which have become trusted trademarks in the industry. With a focus on research and development, the company continues to push the boundaries of medical science, providing effective solutions for wound healing and beyond.Generated from the website

Calder Biosciences, Inc. is a molecular engineering company based in Brooklyn, NY, specializing in the development of innovative vaccines using their proprietary 3D-Vaxlock technology. Their vaccines aim to provide safe, effective, and durable protection against a range of viral infections, including RSV, influenza, and other harmful pathogens. With a focus on global health issues caused by viral infections, Calder Biosciences utilizes state-of-the-art technology and scientific expertise to engineer site-specific, covalent crosslinks in proteins, creating subunit vaccine immunogens that elicit highly protective immune responses. Their commitment to industry leadership, research partnerships, and rigorous safety and efficacy testing positions them as a leading player in the field of vaccine development.Generated from the website